Wang J, Lv X, Li Y et al (2025a) A ROS-responsive hydrogel that targets inflamed mucosa to relieve ulcerative colitis by reversing intestinal mucosal barrier loss
Tesamorelin is FDA-approved for a specific indication
The date of discovery may be related to when the link between the drug and the condition was established
( 10.1111/dom.14725) [DOI] [PMC free article] [PubMed] [Google Scholar] Wilson JM Lin Y Luo MJ Considine G Cox AL Bowsman LM Robins DA Haupt A Duffin KL & Ruotolo G
Among the promising results, the AChEIs stand out, which are generously reported to induce LD
IGF-1 promotes protein synthesis, enhances glucose uptake in skeletal muscle, stimulates lipolysis in adipose tissue, and plays crucial roles in tissue repair and regeneration